ACS Publications. Most Trusted. Most Cited. Most Read
Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity

OR SEARCH CITATIONS

My Activity
Publications

Figure 1Loading Img
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Med. Chem. 1981, 24, 4, 429-434
    article

    Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity
    Click to copy article linkArticle link copied!

    ACS Legacy Archive
    Other Access Options

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 1981, 24, 4, 429–434
    Click to copy citationCitation copied!
    https://doi.org/10.1021/jm00136a012
    Published April 1, 1981
    Request reuse permissions

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Cited By

    Click to copy section linkSection link copied!

    This article is cited by 27 publications.

    1. Xiaobo Xu, Yangyang Wang, Xiao Yu, Xian Liu, Liqiang Hao, Yafei Ji. Palladium-Catalyzed (3 + 2) Annulation of Aromatic Acids by C(sp3)–H Olefination and Decarboxylative Cross-Coupling Reaction. Organic Letters 2024, 26 (7) , 1338-1342. https://doi.org/10.1021/acs.orglett.3c04177
    2. Shawn P. Allwein, Dale R. Mowrey, Daniel E. Petrillo, James J. Reif, Vikram C. Purohit, Karen L. Milkiewicz, Roger P. Bakale, Michael A. Christie, Mark A. Olsen, Christopher J. Neville, and Gregory J. Gilmartin . Development of a Process Route to the FAK/ALK Dual Inhibitor TEV-37440. Organic Process Research & Development 2017, 21 (5) , 740-747. https://doi.org/10.1021/acs.oprd.7b00070
    3. Gregory R. Ott, Mangeng Cheng, Keith S. Learn, Jason Wagner, Diane E. Gingrich, Joseph G. Lisko, Matthew Curry, Eugen F. Mesaros, Arup K. Ghose, Matthew R. Quail, Weihua Wan, Lihui Lu, Pawel Dobrzanski, Mark S. Albom, Thelma S. Angeles, Kevin Wells-Knecht, Zeqi Huang, Lisa D. Aimone, Elizabeth Bruckheimer, Nathan Anderson, Jay Friedman, Sandra V. Fernandez, Mark A. Ator, Bruce A. Ruggeri, and Bruce D. Dorsey . Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry 2016, 59 (16) , 7478-7496. https://doi.org/10.1021/acs.jmedchem.6b00487
    4. Rajesh Kumar Patti, Kristopher V. Waynant, and James W. Herndon . Synthesis of Benzocycloheptanones through Coupling of δ,ε-Unsaturated Chromium Carbene Complexes and 2-Alkynylbenzoyl Derivatives. Organic Letters 2011, 13 (11) , 2848-2851. https://doi.org/10.1021/ol200825j
    5. Jorge E. Angel, Ricardo D. Enriz, Katherindel C. Balza, Ligia B. Angel, Luís E. Perdomo, Lucia Ch. Rodríguez, Akram S. Dabian, Biagina del C. Migliore, María M. Ramírez, José G. Ortega, Jaime E. Charris, Anita. Israel, María del R. Garrido, Simon E. López, Sebastian Rojas, Sebastian A. Andujar. Quinoline analogs of 2-aminoindane as potential central dopaminergic agents. Medicinal Chemistry Research 2019, 28 (8) , 1168-1181. https://doi.org/10.1007/s00044-019-02362-0
    6. Maris Vilums, Jules Heuberger, Laura H. Heitman, Adriaan P. IJzerman. Indanes—Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors. Medicinal Research Reviews 2015, 35 (6) , 1097-1126. https://doi.org/10.1002/med.21352
    7. Frank Boeckler, Peter Gmeiner. The structural evolution of dopamine D3 receptor ligands: Structure–activity relationships and selected neuropharmacological aspects. Pharmacology & Therapeutics 2006, 112 (1) , 281-333. https://doi.org/10.1016/j.pharmthera.2006.04.007
    8. Ao Zhang, Ying Kan, Fuying Li. Recent advances towards the discovery of dopamine receptor ligands. Expert Opinion on Therapeutic Patents 2006, 16 (5) , 587-630. https://doi.org/10.1517/13543776.16.5.587
    9. W R Williams, W J Pugh, P J Nicholls. Receptor regulatory properties evident in the molecular similarity of dopamine receptor ligands and purine nucleotides. Journal of Pharmacy and Pharmacology 2002, 54 (5) , 671-679. https://doi.org/10.1211/0022357021778826
    10. Ellen W. Baxter, Allen B. Reitz. Reductive Aminations of Carbonyl Compounds with Borohydride and Borane Reducing Agents. 2002, 1-714. https://doi.org/10.1002/0471264180.or059.01
    11. Susanne R. Haadsma‐Svensson, Kjell A. Svensson. PNU‐99194A: A Preferential Dopamine D 3 Receptor Antagonist. CNS Drug Reviews 1998, 4 (1) , 42-53. https://doi.org/10.1111/j.1527-3458.1998.tb00040.x
    12. I. van Wijngaarden, W. Soudijn, M.Th.M. Tulp. 5-HT1A receptor ligands. 1997, 17-43. https://doi.org/10.1016/S0165-7208(97)80003-7
    13. G Luz Orfila, Jorge Angel, Marysabel Torres, Yarisma Barbella, Anita Israel. Evidence for a dopaminergic involvement in the renal action of centrally administered JA116a, a novel compound with possible dopaminergic activity, in rats. Journal of Pharmacy and Pharmacology 1994, 46 (5) , 397-399. https://doi.org/10.1111/j.2042-7158.1994.tb03825.x
    14. Kristina Luthman, Anders Vang Jensen, Uli Hacksell, Anders Karlsson, Curt Pettersson. Chiral discrimination of complexes between benzyloxycarbonylglycyl-l-proline and 4-hydroxy-2-dipropylaminoindan in ion-pair chromatography. Journal of Chromatography A 1994, 666 (1-2) , 527-534. https://doi.org/10.1016/0021-9673(94)80414-1
    15. Håkan Wikström. 5 Centrally Acting Dopamine D2 Receptor Ligands: Agonists. 1992, 185-216. https://doi.org/10.1016/S0079-6468(08)70008-0
    16. Uli Hacksell, Anette M. Johansson, Anders Karlén, Charlotta Mellin. Indirect Modelling of Drug-Receptor Interactions. 1991, 135-147. https://doi.org/10.1007/978-1-4684-1354-0_11
    17. Matthew F. Schlecht. Oxidative Rearrangement Reactions. 1991, 815-837. https://doi.org/10.1016/B978-0-08-052349-1.00214-6
    18. Anders Karlsson, Curt Pettersson, Lena Björk, Nils‐Erik Andén, Uli Hacksell. (R)‐ and (S)‐5‐hydroxy‐2‐(dipropylamino)tetralin (5‐OH DPAT): Assessment of optical purities and dopaminergic activities. Chirality 1990, 2 (2) , 90-95. https://doi.org/10.1002/chir.530020206
    19. K. Svensson, S. Hjorth, D. Clark, A. Carlsson, H. Wikstr�m, B. Andersson, D. Sanchez, A. M. Johansson, L. -E. Arvidsson, U. Hacksell, J. L. G. Nilsson. (+)-UH 232 and (+)-UH 242: Novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. Journal of Neural Transmission 1986, 65 (1) , 1-27. https://doi.org/10.1007/BF01249608
    20. Mohamed S. Hossini, Kevin J. McCulloug, Roslyn McKay, George R. Proctor. Ring-expansion by a wittig-prévost sequence. Tetrahedron Letters 1986, 27 (32) , 3783-3786. https://doi.org/10.1016/S0040-4039(00)83880-0
    21. Mustafa Ilhan, Jan R Flynn, John P Long, R K Bhatnagar, Joseph G Cannon. Dopamine receptor agonistic activities of R- and S -enantiomers of 4-hydroxy-2-di-n-propylaminoindan in cat hearts. Journal of Pharmacy and Pharmacology 1985, 37 (5) , 364-365. https://doi.org/10.1111/j.2042-7158.1985.tb05086.x
    22. Carl Kaiser, Tikam Jain. Dopamine receptors: Functions, subtypes and emerging concepts. Medicinal Research Reviews 1985, 5 (2) , 145-229. https://doi.org/10.1002/med.2610050202
    23. Joseph G. Cannon. Dopamine agonists: structure-activity relationships. 1985, 303-414. https://doi.org/10.1007/978-3-0348-9315-2_9
    24. Carl Kaiser. Structure—Activity Relationships of Dopamine Receptor Agonists. 1984, 87-137. https://doi.org/10.1007/978-1-4757-0310-8_4
    25. Tomas de Paulis. Chapter 3. Antipsychotic Agents and Dopamine Agonists. 1983, 21-30. https://doi.org/10.1016/S0065-7743(08)60758-7
    26. J.D. McDermed, H.S. Freeman. Stereochemistry of Dopamine Receptor Agonists. 1982, 179-187. https://doi.org/10.1016/B978-0-08-027391-4.50022-8
    27. U. HACKSELL, L.‐E. ARVIDSSON, U. SVENSSON, J. L. G. NILSSON, H. + WIKSTROEM, P. LINDBERG, D. SANCHEZ, S. HJORTH, A. CARLSSON, L. PAALZOW. ChemInform Abstract: MONOPHENOLIC 2‐(DIPROPYLAMINO)INDANS AND RELATED COMPOUNDS: CENTRAL DOPAMINE‐RECEPTOR STIMULATING ACTIVITY. Chemischer Informationsdienst 1981, 12 (34) https://doi.org/10.1002/chin.198134192
    Download PDF
    Go to Journal of Medicinal Chemistry
    Get e-Alerts
    Get e-Alerts

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 1981, 24, 4, 429–434
    Click to copy citationCitation copied!
    https://doi.org/10.1021/jm00136a012
    Published April 1, 1981
    Request reuse permissions

    Article Views

    387

    Altmetric

    -

    Citations

    27
    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.